top of page

Watch Live: "What's New in PRRT"
with Dr. Amir Iravani

The webinar begins at 12 PM Pacific on Friday, April 14, 2023.

*Closed captioning is available in several languages.

  • Facebook
  • Instagram
  • Twitter
  • Youtube
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Have non-case specific questions for the expert? There will be a live Q&A following the presentation. Submit your questions below.


Amir Iravani, MD, FRACP

Associate Professor

University of Washington, Department of Radiology

Theranostics Director, Fred Hutchinson Cancer Center

Dr. Iravani is a nuclear medicine physician and an Associate Professor of Radiology at the University of Washington and the Theranostics Director at Fred Hutchinson Cancer Center. Before his current role, he worked at the Center for Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Center (PMCC), Melbourne, Australia. He finished training in Nuclear Medicine and Internal Medicine and became a fellow of the Royal College of Physicians in Australia. Dr. Iravani’s fellowship was in Molecular Imaging and Radiopharmaceutical Therapy at PMCC. 


Dr. Iravani has been actively involved in multiple practice-changing theranostic clinical trials and contributed to multiple seminal publications in this field. He is currently a member of multiple national committees in theranostics, including the board of directors of the Society of Nuclear Medicine and Molecular Imaging Theranostic Center of Excellence and the PRRT dosimetry working group at the National Cancer Institute.


Ipsen_Logo (1).png

The information provided is for educational purposes only and does not substitute for medical advice. Talk to your medical team if you have any questions or concerns about your individual care and treatment. The opinions expressed in this program are those of the speakers and do not represent the opinion of LACNETS.

bottom of page